Richard Saynor has been Chief Executive Officer of Sandoz since July 15, 2019. He is a member of the Executive Committee of Novartis.
Mr. Saynor joined Novartis from GlaxoSmithKline (GSK) Pte. Ltd., where he most recently was senior vice president of classic and established products as well as commercial and digital platforms from March to June 2019. During his nine years at GSK, he also served as senior vice president and global head of classic and established products from 2014 to 2019; senior vice president and global head of established products from 2013 to 2014; and senior vice president of classic brands and generics for Europe, Japan, and the emerging markets and Asia-Pacific (EMAP) region from 2010 to 2013. Prior to that, Mr. Saynor held commercial operations leadership roles at Sandoz, serving as Region Head of Asian Markets from 2008 to 2010, and as Region Head of Asia-Pacific, Latin America, Canada and Turkey from 2005 to 2008.
Mr. Saynor earned his Bachelor of Pharmacy from the University of Bradford in the United Kingdom. He is a member of the Royal Pharmaceutical Society in the UK, and served on the board of GSK India from 2018 to 2019.